HighTower Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,796
Closed -$223K 3671
2024
Q1
$223K Sell
2,796
-2,095
-43% -$171K ﹤0.01% 2923
2023
Q4
$381K Buy
4,891
+844
+21% +$62.5K ﹤0.01% 2524
2023
Q3
$286K Buy
+4,047
New +$302K ﹤0.01% 2634
2019
Q4
Sell
-6,569
Closed -$206K 2284
2019
Q3
$206K Buy
6,569
+624
+10% +$19K ﹤0.01% 2044
2019
Q2
$205K Buy
+5,945
New +$192K ﹤0.01% 2047
2018
Q4
Sell
-14,585
Closed -$513K 2203
2018
Q3
$513K Buy
14,585
+1,489
+11% +$59.3K ﹤0.01% 1452
2018
Q2
$534K Sell
13,096
-27,343
-68% -$1.1M ﹤0.01% 1412
2018
Q1
$1.59M Buy
+40,439
New +$1.48M 0.01% 886
2017
Q4
Sell
-7,677
Closed -$363K 2271
2017
Q3
$363K Buy
+7,677
New +$374K ﹤0.01% 1593

Other funds holding ACHC

HighTower Advisors's ACHC Position: Q2 2024 in Review

HighTower Advisors sold out of Acadia Healthcare (ACHC) in Q2 2024, closing a stake of 2,796 shares — an estimated $223K sold.

HighTower Advisors first reported a position in ACHC in Q3 2017 and held it in 9 quarters. The position peaked at $1.59M in Q1 2018. 305 funds tracked by Wall St. Rank hold ACHC as of Q2 2024.

  • HighTower Advisors reported no remaining Acadia Healthcare position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 2,796 Acadia Healthcare shares in Q2 2024, an estimated $223K.
  • HighTower Advisors first reported a position in Acadia Healthcare in Q3 2017 and held it in 9 quarters.
  • HighTower Advisors's Acadia Healthcare position peaked at $1.59M in Q1 2018.
  • 305 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.